celiprolol has been researched along with Metabolic Diseases in 1 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malminiemi, K | 1 |
1 trial available for celiprolol and Metabolic Diseases
| Article | Year |
|---|---|
Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.
Topics: Adult; Analysis of Variance; Antihypertensive Agents; Blood Glucose; Blood Pressure; Celiprolol; Dru | 1995 |